Raymond Emanuel, MD
Child & Adolescent Psychiatry · Ewa Beach, HINPI 1982799748
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 72 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Alkermes, Inc. at 39.5% of the total. Reporting peaked in 2024 at $713 and has fallen 89.5% since, to $75 in 2025. Among child & adolescent psychiatry clinicians in HI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 72 payments — averaging $19.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$557
- Teva Pharmaceuticals USA, Inc.$268
- Indivior Inc.$163
- AbbVie$152
- Neurocrine Biosciences, Inc.$72
- Otsuka America Pharmaceutical, Inc.$63
- plus $134 from 3 others
What the payments were for
- Food & beverage$1,408100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 38 | $557 |
| Teva Pharmaceuticals USA, Inc. | 10 | $268 |
| Indivior Inc. | 7 | $163 |
| AbbVie | 6 | $152 |
| Neurocrine Biosciences, Inc. | 3 | $72 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $53 |
| Johnson & Johnson | 2 | $52 |
| Janssen Scientific Affairs, LLC | 1 | $29 |
How this compares
$1,408 in reported general payments places this provider in the 95th percentile of 30 child & adolescent psychiatry providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Divalproex Sodium | 13 | $482 |
| Quetiapine Fumarate | 19 | $349 |
| Atorvastatin Calcium | 17 | $167 |
| Metformin Hcl | 14 | $134 |
Paid to pharmacies, not to this prescriber.
Other child & adolescent psychiatry in Ewa Beach
- Earlene StrayhornEwa Beach$739
- Olga BriklinEwa Beach$19
- Robert YoungWaianae$2K
- Rodney YamakiAiea$1K
- Kent BooherKaneohe$1K
- Susan MikamiTripler Army Medical Center$600
- Marva LawsonKaneohe$546
- Cathy BellWaipahu$532
- Vandana RaoHonolulu$412
- Chayanin HamadaHonolulu$380
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.